Source: Proteomics. Unidade: FM
Subjects: DOENÇA DE ALZHEIMER, DOENÇAS NEURODEGENERATIVAS, ESCLEROSE AMIOTRÓFICA LATERAL, ESCLEROSE MÚLTIPLA
ABNT
SCHRÖTTER, Andreas et al. Key players in neurodegenerative disorders in focus—New insights into the proteomic profile of Alzheimer's disease, schizophrenia, ALS, and multiple sclerosis—24th HUPO BPP Workshop. Proteomics, v. 16, n. 7, p. 1047-1050, 2016Tradução . . Disponível em: http://onlinelibrary.wiley.com/doi/10.1002/pmic.201600047/epdf. Acesso em: 06 maio 2024.APA
Schrötter, A., Park, Y. M., Marcus, K., Martins-de-Souza, D., Nilsson, P., El Magraoui, F., et al. (2016). Key players in neurodegenerative disorders in focus—New insights into the proteomic profile of Alzheimer's disease, schizophrenia, ALS, and multiple sclerosis—24th HUPO BPP Workshop. Proteomics, 16( 7), 1047-1050. doi:10.1002/pmic.201600047NLM
Schrötter A, Park YM, Marcus K, Martins-de-Souza D, Nilsson P, El Magraoui F, Meyer HE, Grinberg LT. Key players in neurodegenerative disorders in focus—New insights into the proteomic profile of Alzheimer's disease, schizophrenia, ALS, and multiple sclerosis—24th HUPO BPP Workshop [Internet]. Proteomics. 2016 ; 16( 7): 1047-1050.[citado 2024 maio 06 ] Available from: http://onlinelibrary.wiley.com/doi/10.1002/pmic.201600047/epdfVancouver
Schrötter A, Park YM, Marcus K, Martins-de-Souza D, Nilsson P, El Magraoui F, Meyer HE, Grinberg LT. Key players in neurodegenerative disorders in focus—New insights into the proteomic profile of Alzheimer's disease, schizophrenia, ALS, and multiple sclerosis—24th HUPO BPP Workshop [Internet]. Proteomics. 2016 ; 16( 7): 1047-1050.[citado 2024 maio 06 ] Available from: http://onlinelibrary.wiley.com/doi/10.1002/pmic.201600047/epdf